高级检索
当前位置: 首页 > 详情页

ZEB1-Mediated Transcriptional Upregulation of circWWC3 Promotes Breast Cancer Progression through Activating Ras Signaling Pathway.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China [2]Department of Surgical Nursing, Hebei University of Chinese Medicine, Xingyuan Road, Shijiazhuang, Hebei 050200, P.R. China [3]Animal Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China [4]Pathology Department, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China [5]Key Laboratory for Tumor Diagnosis, Prevention and Therapy in Hebei Province, Shijiazhuang, Hebei 050017, P.R. China [6]Breast Diagnostic and Therapeutic Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China
出处:
ISSN:

摘要:
Zinc finger E-box binding homeobox 1 (ZEB1) has been widely recognized as an important driver of tumor growth and metastasis. However, nothing is known about ZEB1-regulated circular (circ)RNAs in cancer. In the current study, we evaluated the function of a novel ZEB1-regulated circRNA derived from the WWC3 gene locus, circWWC3 in breast cancer progression. We found that ZEB1 upregulated circWWC3 expression but not the linear WWC3 mRNA expression. circWWC3 is highly expressed in breast cancer tissues and is associated with the poor prognosis of breast cancer patients. Silencing of circWWC3 significantly suppresses the proliferation, migration, and invasion of breast cancer cells. Mechanically, circWWC3 upregulates multiple oncogenes' expression of the Ras signaling pathway through acting as the sponge of microRNA (miR)-26b-3p and miR-660-3p. Moreover, short hairpin (sh)RNA-mediated knockdown of circWWC3 partially antagonized ZEB1-mediated breast cancer growth and metastasis in vivo. Our findings reveal that ZEB1-mediated upregulation of circWWC3 promotes breast cancer progression through activating Ras signaling pathway, which provides a potential therapeutic target and prognostic biomarker for breast cancer. Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验
JCR分区:
出版当年[2020]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2024]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China
共同第一作者:
通讯作者:
通讯机构: [1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China [5]Key Laboratory for Tumor Diagnosis, Prevention and Therapy in Hebei Province, Shijiazhuang, Hebei 050017, P.R. China [6]Breast Diagnostic and Therapeutic Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China [*1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China [*2]Breast Diagnostic and Therapeutic Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42313 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号